- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02502487
Dorsal Penile Nerve Block for Rigid Cystoscopy in Men
March 18, 2020 updated by: Yan Qiu, West China Hospital
Dorsal Penile Nerve Block for Rigid Cystoscopy in Men: a Single-center, Randomized, Double-blind and Placebo-controlled Study
This study will determine the effectiveness and safety of dorsal penile nerve block (DPNB) in men undergoing rigid cystoscopy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Pain is common in men undergoing rigid cystoscopy.
Even with application of a lubricant containing 2% lidocaine, about 76% men suffer from mild to severe pain when undergoing rigid cystoscopy, and approximately 27% men could still feel mild to moderate pain 7 days after the procedure.
The most painful part of the procedure for men is when the cystoscope passes through the membranous urethra.
Song et al did autopsy on males found dorsal nerve of the penis (DNP), the terminal branch of the pudendal nerve, innervates the membranous urethra in 53.3% specimens.
In addition, urethral mucosa has branches of DNP innervated.
Dorsal penile nerve block (DPNB) is usually used for circumcision in children and it has been shown to provide effective analgesia for penile surgeries.
According to the evidence that some DNP branches innervate membranous urethra and urethra mucosa and most pain originates from cystoscope passing through membranous urethra, we speculated that DPNB could overall reduce pain level in men during rigid cystoscopy.
Study Type
Interventional
Enrollment (Actual)
258
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610041
- West China Hospital of Sichuan University, Department of Anesthesiology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 71 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) Physical Status I-II
- Without history of urethral or prostatic surgery
- Without respiration or circulation disorders
- Without chronic pain
Exclusion Criteria:
- Allergy to local anesthetics
- Coagulation disorder or usage of antiplatelet drugs
- Infection at the site of puncture point
- Severe urethral stenosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Tetracaine gel group
Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
|
1% Tetracaine gel instilled into urethra
|
|
Experimental: Dorsal penile nerve block group
Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
|
Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
|
|
Experimental: Combination group
Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
|
1% Tetracaine gel instilled into urethra
Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale (VAS) for Pain
Time Frame: at cystoscopic inspection of external sphincter
|
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure.
0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain.
Patients were asked the VAS score to express the degree of pain at each time point.
|
at cystoscopic inspection of external sphincter
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale (VAS) for Pain
Time Frame: before gel administration
|
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure.
0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain.
Patients were asked the VAS score to express the degree of pain at each time point.
|
before gel administration
|
|
Visual Analog Scale (VAS) for Pain
Time Frame: at cystoscopic inspection of penile and bulbar urethra
|
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure.
0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain.
Patients were asked the VAS score to express the degree of pain at each time point.
|
at cystoscopic inspection of penile and bulbar urethra
|
|
Visual Analog Scale (VAS) for Pain
Time Frame: at cystoscopic inspection of prostate and bladder
|
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure.
0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain.
Patients were asked the VAS score to express the degree of pain at each time point.
|
at cystoscopic inspection of prostate and bladder
|
|
Visual Analog Scale (VAS) for Pain
Time Frame: after withdrawal of cystoscope
|
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure.
0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain.
Patients were asked the VAS score to express the degree of pain at each time point.
|
after withdrawal of cystoscope
|
|
Heart Rate Before Gel Administration
Time Frame: before gel administration
|
before gel administration
|
|
|
Heart Rate at Cystoscopic Inspection of Penile and Bulbar Urthra
Time Frame: at cystoscopic inspection of penile and bulbar urethra
|
at cystoscopic inspection of penile and bulbar urethra
|
|
|
Heart Rate at Cystoscopic Inspection of External Sphincter
Time Frame: at cystoscopic inspection of external sphincter
|
at cystoscopic inspection of external sphincter
|
|
|
Heart Rate After Withdrawal of Cystoscope
Time Frame: after withdrawal of cystoscope
|
after withdrawal of cystoscope
|
|
|
Mean Arterial Pressure Before Gel Administration
Time Frame: before gel administration
|
before gel administration
|
|
|
Mean Arterial Pressure at Cystoscopic Inspection of Penile and Bulbar Urthra
Time Frame: at cystoscopic inspection of penile and bulbar urthra
|
at cystoscopic inspection of penile and bulbar urthra
|
|
|
Mean Arterial Pressure at Cystoscopic Inspection of External Sphincter
Time Frame: at cystoscopic inspection of external sphincter
|
at cystoscopic inspection of external sphincter
|
|
|
Mean Arterial Pressure After Withdrawal of Cystoscope
Time Frame: after withdrawal of cystoscope
|
after withdrawal of cystoscope
|
|
|
Oxygen Saturation by Pulse Before Gel Administration
Time Frame: before gel administration
|
before gel administration
|
|
|
Oxygen Saturation by Pulse at Cystoscopic Inspection of Penile and Bulbar Urthra
Time Frame: at cystoscopic inspection of penile and bulbar urthra
|
at cystoscopic inspection of penile and bulbar urthra
|
|
|
Oxygen Saturation by Pulse at Cystoscopic Inspection of External Sphincter
Time Frame: at cystoscopic inspection of external sphincter
|
at cystoscopic inspection of external sphincter
|
|
|
Oxygen Saturation by Pulse After Withdrawal of Cystoscope
Time Frame: after withdrawal of cystoscope
|
after withdrawal of cystoscope
|
|
|
Breath Rate Before Gel Administration
Time Frame: before gel administration
|
before gel administration
|
|
|
Breath Rate at Cystoscopic Inspection of Penile and Bulbar Urthra
Time Frame: at cystoscopic inspection of penile and bulbar Urthra
|
at cystoscopic inspection of penile and bulbar Urthra
|
|
|
Breath Rate at Cystoscopic Inspection of External Sphincter
Time Frame: at cystoscopic inspection of external sphincter
|
at cystoscopic inspection of external sphincter
|
|
|
Breath Rate After Withdrawal of Cystoscope
Time Frame: after withdrawal of cystoscope
|
after withdrawal of cystoscope
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Guizhi Du, Doctor, West China Hospital of Sichuan University, Department of Anesthesiology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, Sylvester RJ, Kaasinen E, Bohle A, Palou Redorta J, Roupret M; European Association of Urology. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013 Oct;64(4):639-53. doi: 10.1016/j.eururo.2013.06.003. Epub 2013 Jun 12.
- Ramsey EW, Elhilali M, Goldenberg SL, Nickel CJ, Norman R, Perreault JP, Piercy B, Trachtenberg J. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council. J Urol. 2000 Feb;163(2):499-502.
- Goldfischer ER, Cromie WJ, Karrison TG, Naszkiewicz L, Gerber GS. Randomized, prospective, double-blind study of the effects on pain perception of lidocaine jelly versus plain lubricant during outpatient rigid cystoscopy. J Urol. 1997 Jan;157(1):90-4.
- Seklehner S, Remzi M, Fajkovic H, Saratlija-Novakovic Z, Skopek M, Resch I, Duvnjak M, Hruby S, Librenjak D, Hubner W, Breinl E, Riedl C, Engelhardt PF. Prospective multi-institutional study analyzing pain perception of flexible and rigid cystoscopy in men. Urology. 2015 Apr;85(4):737-41. doi: 10.1016/j.urology.2015.01.007.
- Taghizadeh AK, El Madani A, Gard PR, Li CY, Thomas PJ, Denyer SP. When does it hurt? Pain during flexible cystoscopy in men. Urol Int. 2006;76(4):301-3. doi: 10.1159/000092051.
- Song LJ, Lu HK, Wang JP, Xu YM. Cadaveric study of nerves supplying the membranous urethra. Neurourol Urodyn. 2010 Apr;29(4):592-5. doi: 10.1002/nau.20768.
- Kozacioglu Z, Kiray A, Ergur I, Zeybek G, Degirmenci T, Gunlusoy B. Anatomy of the dorsal nerve of the penis, clinical implications. Urology. 2014 Jan;83(1):121-4. doi: 10.1016/j.urology.2013.07.075. Epub 2013 Nov 12.
- Kirya C, Werthmann MW Jr. Neonatal circumcision and penile dorsal nerve block--a painless procedure. J Pediatr. 1978 Jun;92(6):998-1000. doi: 10.1016/s0022-3476(78)80386-2.
- Qiu Y, Liu X, Wei W, Du G. Dorsal penile nerve block alleviates pain in men undergoing rigid cystoscopy: A single-center, randomized, double-blind, and placebo-controlled trial. BJUI Compass. 2021 Feb 5;2(4):260-266. doi: 10.1002/bco2.76. eCollection 2021 Jul.
- Qiu Y, Hu AM, Liu J, Du GZ. Dorsal penile nerve block for rigid cystoscopy in men: study protocol for a randomized controlled trial. Trials. 2016 Mar 18;17(1):147. doi: 10.1186/s13063-016-1281-9.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
July 6, 2015
First Submitted That Met QC Criteria
July 15, 2015
First Posted (Estimate)
July 20, 2015
Study Record Updates
Last Update Posted (Actual)
March 31, 2020
Last Update Submitted That Met QC Criteria
March 18, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WestChinaHAesthesia-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
noiVita SrlsUniversity of Eastern PiedmontCompletedCervical Pain | Pain Management | Lumbar Pain | Muscular | Chronic Pain (Back / Neck)Italy
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
Chinese University of Hong KongNot yet recruitingPain, Acute | Chronic Post Operative Pain | Pain, ChronicHong Kong
-
University of SaskatchewanRoyal University Hospital FoundationCompletedPain | Pain, Acute | Pain, Chronic | Pain, IntractableCanada
-
Kyowa Kirin Co., Ltd.Completed
Clinical Trials on Tetracaine
-
Cetylite IndustriesCompletedNo Disease State or ConditionUnited States
-
Wenzhou Medical UniversityCompleted
-
New York Presbyterian Brooklyn Methodist HospitalUnknown
-
Fraser HealthCompleted
-
Cetylite IndustriesCompleted
-
Jazz PharmaceuticalsWithdrawnHealthy | AnesthesiaUnited Kingdom
-
West China HospitalUnknownCatheter Site DiscomfortChina
-
INTEGRIS Southwest Medical CenterCompleted
-
Pontificia Universidad Catolica de ChileNot yet recruiting
-
Vrije Universiteit BrusselUniversitair Ziekenhuis BrusselCompletedLacerations | Pain Management | Wound Repair | Acute Traumatic WoundsBelgium